These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 31593308)
21. Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Lim SM; Kang SS; Kim DK; Lee SH; Synn CB; Baek S; Yang SM; Han YJ; Kim MH; Han H; Na K; Kim YT; Yun MR; Kim JH; Byeon Y; Kim YS; Lee JB; Hong MH; Curtin JC; Patel B; Bergiers I; Pyo KH; Cho BC Cancer Res Commun; 2024 Jul; 4(7):1748-1764. PubMed ID: 38916448 [TBL] [Abstract][Full Text] [Related]
23. HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC. Zeng H; Song X; Ji J; Chen L; Liao Q; Ma X BMC Cancer; 2020 Aug; 20(1):796. PubMed ID: 32831060 [TBL] [Abstract][Full Text] [Related]
24. Assessment of Immune Cell Populations in Tumor Tissue and Peripheral Blood Samples from Head and Neck Squamous Cell Carcinoma Patients. Caruntu A; Moraru L; Surcel M; Munteanu A; Tanase C; Constantin C; Zurac S; Caruntu C; Neagu M Anal Cell Pathol (Amst); 2021; 2021():2328218. PubMed ID: 34692375 [TBL] [Abstract][Full Text] [Related]
25. The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments. Outh-Gauer S; Morini A; Tartour E; Lépine C; Jung AC; Badoual C Head Neck Pathol; 2020 Jun; 14(2):330-340. PubMed ID: 32124416 [TBL] [Abstract][Full Text] [Related]
26. High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Kindt N; Descamps G; Seminerio I; Bellier J; Lechien JR; Mat Q; Pottier C; Delvenne P; Journé F; Saussez S Oral Oncol; 2017 Apr; 67():183-191. PubMed ID: 28351575 [TBL] [Abstract][Full Text] [Related]
27. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer. Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881 [TBL] [Abstract][Full Text] [Related]
28. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665 [TBL] [Abstract][Full Text] [Related]
29. Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy. Puntigam LK; Jeske SS; Götz M; Greiner J; Laban S; Theodoraki MN; Doescher J; Weissinger SE; Brunner C; Hoffmann TK; Schuler PJ Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707816 [TBL] [Abstract][Full Text] [Related]
30. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells. Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160 [TBL] [Abstract][Full Text] [Related]
31. Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma. Xu X; Li R; Zhang L; Zhu G; Ren D; Wu L; Gong X Diagn Pathol; 2021 Nov; 16(1):110. PubMed ID: 34823553 [TBL] [Abstract][Full Text] [Related]
32. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma. Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment. Kim DH; Ahn JS; Kang M; Park G; Lim Y; Hwang S; Ock CY; Koh J; Chung EJ; Kwon SK; Jeon YK; Jung KC; Ahn SH; Keam B Cells; 2024 Sep; 13(18):. PubMed ID: 39329741 [TBL] [Abstract][Full Text] [Related]
34. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors. de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916 [TBL] [Abstract][Full Text] [Related]
36. Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma. Hartman DJ; Ahmad F; Ferris RL; Rimm DL; Pantanowitz L Oral Oncol; 2018 Nov; 86():278-287. PubMed ID: 30409313 [TBL] [Abstract][Full Text] [Related]
37. Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice. Brand M; Laban S; Theodoraki MN; Doescher J; Hoffmann TK; Schuler PJ; Brunner C Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383676 [TBL] [Abstract][Full Text] [Related]
38. Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab. Ladányi A; Kapuvári B; Papp E; Tóth E; Lövey J; Horváth K; Gődény M; Remenár É Head Neck; 2019 May; 41(5):1237-1245. PubMed ID: 30548478 [TBL] [Abstract][Full Text] [Related]
40. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma. Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]